CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in participants with human epidermal growth factor 2 (HER2)-expressing (immunohistochemistry \[IHC\] 3+/2+/1+) advanced high-grade epithelial ovarian...
Phase 3
Taipei, Taiwan and 207 other locations
Ovarian cancer (OC) is a lethal disease. The purpose of this study is to assess the safety, pharmacokinetics and efficacy of ABBV90 ...
Phase 1
Taipei, Taiwan and 16 other locations
choice of chemotherapy in subjects with platinum-resistant ovarian cancer whose tumors are positive for cyclin E1 protein ...
Phase 3
Taipei, Taiwan and 57 other locations
as "study drug". The study is focused on patients who have advanced ovarian cancer.The aim of the study is to see how safe, tolerab...
Phase 2
Taipei, Taiwan and 53 other locations
Researchers are looking for new ways to treat ovarian cancer (OC). Current treatment for OC may start with surgery to remove as muc...
Phase 3
Taipei, Taiwan and 117 other locations
cycles of a standard six-cycle chemotherapy regimen (paclitaxel and carboplatin), for the treatment of subjects with newly diagnosed advanced ovarian...
Phase 3
Taipei, Taiwan and 149 other locations
This study will evaluate the safety and efficacy of R-DXd therapy in participants with ovarian, peritoneal, or fallopian tube cancer...
Phase 2, Phase 3
Taipei, Taiwan and 151 other locations
following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based...
Phase 3
Taipei, Taiwan and 237 other locations
tirumotecan with or without bevacizumab live longer without the cancer getting worse than those who receive standard of care treatment....
Phase 3
Taipei, Taiwan and 180 other locations
Sofetabart Mipitecan (Sofe-M) for people with certain types of ovarian, peritoneal, and fallopian tube cancers. Part A enrolls part...
Phase 3
Taipei, Taiwan and 264 other locations
Clinical trials
Research sites
Resources
Legal